Prediction and prognostic significance of ALOX12B and PACSIN1 expression in gastric cancer by genome-wide RNA expression and methylation analysis

Liu, Zhiping; Li, Lei; Li, Xindi; Hua, Mingtao; Sun, Huaqing; Shen-gui, Zhang

doi:10.21037/jgo-21-508

Cited by 6 publications

(4 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, high expression of PACSIN1 was associated with advanced stages, lymph node metastasis and poor prognosis. These findings suggested that PACSIN1 may function as an oncogene in GC, which is in line with the findings of Liu et al [23]. PACSIN1, an autophagy regulator, promotes lysosomal fusion and autophagy.…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I

Liu,

Li,

Muhammad

et al. 2024

ABBS

View full text Add to dashboard Cite

Gastric cancer (GC) is a common gastrointestinal system malignancy. PACSIN1 functions as an oncogene in various cancers. This study aims to investigate the potential of PACSIN1 as a target in GC treatment. Gene expression is determined by RT-qPCR, immunofluorescence staining, and immunohistochemistry assay. FISH is performed to determine the colocalization of PACSIN1 and the major histocompatibility complex (MHC-I). Cytokine release and cell functions are analyzed by flow cytometry. In vivo assays are also conducted. Histological analysis is performed using H&E staining. The results show that PACSIN1 is overexpressed in GC patients, especially in those with immunologically-cold tumors. A high level of PACSIN1 is associated with poor prognosis. PACSIN1 deficiency inhibits autophagy but increases antigen presentation in GC cells. Moreover, PACSIN1 deficiency inhibits the lysosomal fusion and selective autophagy of MHC-I, increases CD8 + T-cell infiltration, and suppresses tumor growth and liver metastasis in vivo. Additionally, PACSIN1 knockout enhances the chemosensitivity of cells to immune checkpoint blockade. In summary, PACSIN1 mediates lysosomal fusion and selective autophagy of MHC-I and suppresses antigen presentation and CD8 + T-cell infiltration, thus inhibiting antitumor immunity in GC.

show abstract

Section: Discussionsupporting

confidence: 91%

“…For instance, overexpressed PACSIN1 is associated with poor overall survival in luminal breast cancer patients [22]. Overexpressed PACSIN1 predicts the metastasis of GC [23]. However, the underlying molecular mechanisms are still unclear.…”

Section: Introductionmentioning

confidence: 99%

PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I

Liu,

Li,

Muhammad

et al. 2024

ABBS

View full text Add to dashboard Cite

show abstract

“…Previous research has found a weak to moderate correlation between gene expression and DNA methylation, and it has only identified a small subset of genes that are highly controlled by DNA methylation. [29,30] The predictive value of JAM3 DNA methylation was also explored. Among GC patients, we discovered that a hypermethylated JAM3 gene was associated with better OS and progression-free survival.…”

Section: Discussionmentioning

confidence: 99%

Prognostic significance of JAM 3 in gastric cancer: An observational study from TCGA and GEO

et al. 2023

View full text Add to dashboard Cite

Junctional adhesion molecule 3 (JAM3) can be used as a prognostic marker in multiple cancer types. However, the potential prognostic role of JAM3 in gastric cancer (GC) remains unclear. The purpose of this research was to gauge JAM3 expression and methylation as potential biomarkers for GC patient survival. Through bioinformatics research, we analyzed JAM3 expression, methylation, prognosis, and immune cell infiltrations. JAM3 methylation acts as a negative regulator of JAM3, leading to reduced expression of JAM3 in GC tissues relative to normal tissues. Patients with GC who expressed little JAM3 have a better chance of living a long time free of the disease, according to the Cancer Genome Atlas (TCGA) database. Through univariate and multivariate Cox regression analysis, inadequate JAM3 expression was labeled as an isolated indicator for overall survival (OS). The GSE84437 dataset was also used to confirm JAM3 prognostic role in GC, with consistent findings. A meta-analysis also found that low levels of JAM3 expression were significantly associated with longer OS. Finally, there was a strong correlation between JAM3 expression and a subset of immune cells. According to the TCGA database, low JAM3 expression could predict favorable OS and progression-free-survival (PFS) in GC patients (P < .05). The univariate and multivariate Cox regression demonstrated that low JAM3 expression was independent biomarker for OS (P < .05). Moreover, GSE84437 dataset was utilized to verify the prognostic role of JAM3 in GC, and the similar results were reached (P < .05). A meta-analysis revealed that low JAM3 expression was closely relevant to better OS. Finally, JAM3 expression exhibited a close correlation with some immune cells (P < .05). JAM3 might be a viable predictive biomarker and likely plays a crucial part in immune cell infiltration in individuals with GC.

show abstract

“…The predictive characteristics of some gene expressions had great significance in the application of clinical prognosis and identification of biomarkers. Studies showed that compared with the STAD patients without metastasis, the expression levels of ALOX12B and PACSIN1 were higher in patients with tumor metastasis, and the survival rate of patients with high expression was significantly lower than that of patients without metastasis [ 8 ]. These two genes may be potential biomarkers of metastasis and poor prognosis, which provide more information for follow-up comprehensive treatment and diagnosis of GC.…”

Section: Introductionmentioning

confidence: 99%

Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets

Jiang¹,

Lin²,

Huang³

et al. 2022

Eur J Med Res

View full text Add to dashboard Cite

Background Stomach adenocarcinomas (STAD) are the most common malignancy of the human digestive system and represent the fourth leading cause of cancer-related deaths. As early-stage STAD are generally mild or asymptomatic, patients with advanced STAD have short overall survival. Early diagnosis of STAD has a considerable influence on clinical outcomes. Methods The mRNA expression data and clinical indicators of STAD and normal tissues were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. The gene expression differences were analyzed by R packages, and gene function enrichment analysis was performed. Kaplan–Meier method and univariate Cox proportional risk regression analysis were used to screen differential expressed genes (DEGs) related to survival of STAD patients. Multivariate Cox proportional risk regression analysis was used to further screen and determine the prognostic DEGs in STAD patients, and to construct a multigene prognostic prediction signature. The accuracy of predictive signature was tested by receiver operating characteristic (ROC) curve software package, and the nomogram of patients with STAD was drawn. Cox regression was used to investigate the correlation between multigene prognostic signature and clinical factors. The predictive performance of this model was compared with two other models proposed in previous studies using KM survival analysis, ROC curve analysis, Harrell consistency index and decision curve analysis (DCA). qRT-PCR and Western blot were used to verify the expression levels of prognostic genes. The pathways and functions of possible involvement of features were predicted using the GSEA method. Results A total of 569 early-stage specific DEGs were retrieved from TCGA-STAD dataset, including 229 up-regulated genes and 340 down-regulated genes. Enrichment analysis showed that the early-stage specific DEGs were associated with cytokine–cytokine receptor interaction, neuroactive ligand–receptor interaction, and calcium signaling pathway. Multiple Cox regression algorithm was used to identify 10 early-stage specific DEGs associated with overall survival (P < 0.01) of STAD patients, and a multi-mRNA prognosis signature was established. The patients were divided into high-risk group and low-risk group according to the risk score. In the training set, the prognostic signature was positively correlated with tumor size and stage (P < 0.05), survival curve (P < 0.001) and time-dependent ROC (AUC = 0.625). In the training dataset and test dataset, the both signatures had good predictive efficiencies. Cox regression and DCA analysis revealed that the prognostic signature was an independent factor and had a better predict effect than the conventional TNM stage classification method and the earlier published biomarkers on the prognosis of STAD patients. Conclusion In this study, based on the early-stage specifically expressed genes, the prognostic signature constructed through TCGA and GEO datasets may become an indicator for clinical prognosis assessment of STAD and a new strategy for targeted therapy in the future.

show abstract

Prediction and prognostic significance of ALOX12B and PACSIN1 expression in gastric cancer by genome-wide RNA expression and methylation analysis

Cited by 6 publications

References 48 publications

PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I

PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I

Prognostic significance of JAM 3 in gastric cancer: An observational study from TCGA and GEO

Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets

Contact Info

Product

Resources

About